中期业绩充分证明了觅瑞在癌症早筛领域的商业化能力。据IPO早知道消息，Mirxes Holding Company Limited（2629.HK，后简称Mirxes觅瑞）于8月25日发布了截至2025年6月30日的中期业绩。值得一提的是，根据 8月22日恒生指数公司公告，Mirxes觅瑞（MIRXES - B）成功被纳入恒生综合指数。相关变动将9月5日收市后正式实施，并于9月8日起生效。届时，...
Source Link中期业绩充分证明了觅瑞在癌症早筛领域的商业化能力。据IPO早知道消息，Mirxes Holding Company Limited（2629.HK，后简称Mirxes觅瑞）于8月25日发布了截至2025年6月30日的中期业绩。值得一提的是，根据 8月22日恒生指数公司公告，Mirxes觅瑞（MIRXES - B）成功被纳入恒生综合指数。相关变动将9月5日收市后正式实施，并于9月8日起生效。届时，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.